Hainan Poly Pharm Future Growth
Future criteria checks 3/6
Hainan Poly Pharm is forecast to grow earnings at 105.6% per annum. EPS is expected to grow by 106% per annum.
Key information
105.6%
Earnings growth rate
106.0%
EPS growth rate
| Pharmaceuticals earnings growth | 18.9% |
| Revenue growth rate | n/a |
| Future return on equity | n/a |
| Analyst coverage | None |
| Last updated | 08 Jul 2024 |
Recent future growth updates
No updates
Recent updates
What Hainan Poly Pharm. Co., Ltd's (SZSE:300630) 46% Share Price Gain Is Not Telling You
Oct 08
Hainan Poly Pharm. Co., Ltd (SZSE:300630) Stocks Shoot Up 28% But Its P/E Still Looks Reasonable
Aug 16It's Down 27% But Hainan Poly Pharm. Co., Ltd (SZSE:300630) Could Be Riskier Than It Looks
Apr 21A Piece Of The Puzzle Missing From Hainan Poly Pharm. Co., Ltd's (SZSE:300630) 27% Share Price Climb
Mar 06Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 9/30/2024 | 1,307 | -106 | -322 | -198 | N/A |
| 6/30/2024 | 1,272 | -68 | -279 | -174 | N/A |
| 3/31/2024 | 1,396 | 86 | -301 | -54 | N/A |
| 12/31/2023 | 1,304 | 86 | -435 | 113 | N/A |
| 9/30/2023 | 872 | -67 | -426 | 283 | N/A |
| 6/30/2023 | 1,294 | 104 | -504 | 337 | N/A |
| 3/31/2023 | 1,466 | 200 | -837 | 261 | N/A |
| 12/31/2022 | 1,619 | 295 | -809 | 228 | N/A |
| 9/30/2022 | 1,743 | 482 | -869 | 83 | N/A |
| 6/30/2022 | 1,681 | 479 | -950 | 166 | N/A |
| 3/31/2022 | 1,603 | 457 | -689 | 168 | N/A |
| 1/1/2022 | 1,509 | 417 | -647 | 157 | N/A |
| 9/30/2021 | 1,543 | 513 | -737 | 380 | N/A |
| 6/30/2021 | 1,410 | 474 | -571 | 343 | N/A |
| 3/31/2021 | 1,291 | 449 | -495 | 337 | N/A |
| 12/31/2020 | 1,189 | 407 | -504 | 332 | N/A |
| 9/30/2020 | 1,124 | 380 | -385 | 251 | N/A |
| 6/30/2020 | 1,000 | 340 | -356 | 228 | N/A |
| 3/31/2020 | 964 | 311 | -355 | 217 | N/A |
| 12/31/2019 | 950 | 301 | -187 | 215 | N/A |
| 9/30/2019 | 830 | 266 | -161 | 21 | N/A |
| 6/30/2019 | 725 | 231 | -197 | 102 | N/A |
| 3/31/2019 | 687 | 220 | -140 | 98 | N/A |
| 12/31/2018 | 624 | 181 | -157 | 95 | N/A |
| 9/30/2018 | 528 | 159 | -185 | 206 | N/A |
| 6/30/2018 | 445 | 137 | N/A | 99 | N/A |
| 3/31/2018 | 371 | 119 | N/A | 95 | N/A |
| 12/31/2017 | 325 | 98 | N/A | 94 | N/A |
| 9/30/2017 | 298 | 89 | N/A | 84 | N/A |
| 6/30/2017 | 275 | 78 | N/A | 74 | N/A |
| 3/31/2017 | 260 | 72 | N/A | 56 | N/A |
| 12/31/2016 | 248 | 70 | N/A | 56 | N/A |
| 6/30/2016 | 214 | 56 | N/A | 43 | N/A |
| 3/31/2016 | 193 | 50 | N/A | 47 | N/A |
| 12/31/2015 | 203 | 51 | N/A | 58 | N/A |
| 12/31/2014 | 165 | 37 | N/A | 57 | N/A |
| 12/31/2013 | 132 | 25 | N/A | 45 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 300630 is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2.8%).
Earnings vs Market: 300630 is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: 300630 is expected to become profitable in the next 3 years.
Revenue vs Market: Insufficient data to determine if 300630's revenue is forecast to grow faster than the CN market.
High Growth Revenue: Insufficient data to determine if 300630's revenue is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if 300630's Return on Equity is forecast to be high in 3 years time